Lokivetmab

• UNSPSC Description:

  Lokivetmab (Anti-Canine IL31 Recombinant Antibody) is an anti-canine IL-31 monoclonal antibody that can be used for the research of atopic dermatitis (AD) in dogs[1].

• Target Antigen:

  Interleukin Related

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/lokivetmab.html

• Purity:

  96.12

• Solubility:

  H2O

• Smiles:

  [Lokivetmab]

• References & Citations:

  [1]Meichner K, et al. Lokivetmab therapy for pruritus in a dog with cutaneous mastocytosis. Vet Dermatol. 2019 Feb;30(1):73-e22.

• Shipping Conditions:

  Dry Ice

• Storage Conditions:

  Store at -80°C for 2 years

• Clinical Information:

  No Development Reported

• CAS Number:

  1533403-95-0